J&J on the hook for $302m in pelvic mesh dispute

An appeals court in California has upheld a lower court ruling that ordered Johnson & Johnson to pay substantial penalties for deceptive marketing of its pelvic mesh implants used to treat conditions like pelvic organ prolapse.